<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1615816415302394&amp;ev=PageView&amp;noscript=1">

NEWS

Learn more about what's going on in the organization. Subscribe to our news articles to receive email alerts whenever we post something new!

Jeff Ketelhut Joins SVA Life Sciences as Consultant, Biopharma/Cell & Gene Therapy vCIO

jeff-ketelhut-joins-as-consultant-with-sva-life-sciences

MADISON, WI (4/14/21) SVA Life Sciences, a division of the SVA family of companies, is pleased to welcome Jeff Ketelhut to the firm as Life Sciences Consultant and Biopharma/Cell & Gene Therapy virtual Chief Information Officer (vCIO). SVA Life Sciences is a division of SVA Consulting that serves leaders in emerging and high growth biopharma.

Jeff brings nearly three decades of collective experiences in biopharma, specializing in delivering strategic business and IT solutions that allow emerging companies the ability to efficiently scale and operate, as well as providing strategic leadership to help those companies commercialize their first product candidate. He is adept at generating the intra-dependent cooperation required amongst business and IT leaders to create a robust and nimble enterprise.

Jeff has personally witnessed the positive effects of sponsoring exceptional team leadership, staff development, and creating strong partnerships between clients and vendors. He has worked with small IT budgets and minimal resources supporting emerging capabilities and can easily empathize and adapt to the innumerable challenges that arise.

Jeff has a diverse background as a business practitioner in Materials Management, Master Scheduling, Warehouse Management, and Supply Chain Management and Procurement. In addition, he has extensive ERP, MES, and CRM implementation experience while leading global programs.

Jeff spent 5 years of increasing responsibility at the computer printer manufacturer Dataproducts Corporation, and has a collection of 29 years of experience in Life Sciences at Amgen, Kythera Biotherapeutics, Atara Biotherapeutics, and Arrowhead Pharma before joining SVA Life Sciences.

“Jeff is an outstanding addition to the SVA team and we are thrilled to have him on board," says Bryan Bechtoldt, President and Principal of SVA Consulting. "His wealth of knowledge and extensive experience in the life sciences space will be a major asset to us as we continue to help clients build stronger businesses and provide them with Measurable Results.™"

Learn More About Jeff

Fill out the form below to receive an email alert when news is posted.

Trusted By

verastem-oncology-logo-3x
exact-sciences-logo-3x
nordic-logo-3x
cleary-logo-3x
wra-logo-3x
giordanos-logo-3x